CapitaLand Unveils 14 Billion Geneo Life Sciences Hub in Science Park Redevelopment The HighStakes Business of Orchid Breeding A DecadeLong Investment with Lucrative Potential SpaceX and OpenAI Potential IPOs Could Surpass Berkshire Hathaway in Market Value Traders Suggest Consumer Sentiment Plunges to Record Low in May as Surging Gas Prices Weigh on Economic Outlook SpaceX Starship V3 Rocket Lifts Off in Historic Test Flight OpenAI Gains Early Advantage in AI IPO Race as Confidential Filing Reports Emerge SUNC Q1 2026 Earnings Significant EPS Miss Raises Concerns ArcBest Q1 2026 Earnings EPS Surprise of 1536 Drives Positive Market Response Park Aerospace Corp Q1 2026 Earnings EPS of 015 Exceeds Prior Year Performance Stock Rises 488 DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower IO Biotech Q3 2025 Earnings EPS Beat Highlights Cost Discipline Amid Ongoing Pipeline Development ACNT Q1 2025 Earnings EPS Misses Estimates Amid Market Challenges Ternium SA TX Surges Over 5 as Steel Demand Optimism Drives Breakout Above Key Levels Saba Capital Income Opportunities Fund SBI BRW Holds Steady at 675 as Consolidation Persists Ecopetrol EC Slips 101 as Energy Sector Headwinds Persist Key Support at 1403 in Focus Precision Drilling PDS Holds Steady Near 96 Consolidation Within Established Range Harvard Ave Acquisition Unit HAVAU Inches Higher Above Support Dicks Sporting Goods Inc DKS Q1 2026 Earnings EPS Surges Past Estimates Stock Rises Indaptus Therapeutics Inc INDP Q4 2025 Earnings Deeper Loss Yet Shares Surge on Pipeline Progress NWN Q1 2026 Earnings EPS Misses Estimates Stock Declines 18 Data IO Corporation DAIO Q1 2026 Earnings WiderthanExpected Loss Weighs on Sentiment Yet Stock Rises UTSI Q4 2019 Earnings EPS Misses Estimates by Wide Margin WTW Q1 2026 Earnings Adjusted EPS Edges Past Estimates as Stock Holds Steady Family Resort Sector Shows Strength as Travel Demand Drives Luxury AllInclusive Expansion in 2026 Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline BioXcel Therapeutics BTAI Slips 088 as Stock Tests Support Near 107